NYLIM
IDXX icon

New York Life Investment Management’s Idexx Laboratories IDXX Stock Holding History

New York Life Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.19M Sell
11,759
-118
-1% -$66.2K 0.04% 308
2026
Q1 		$6.67M Buy
11,877
+287
+2% +$184K 0.06% 270
2025
Q4 		$7.84M Sell
11,590
-89
-0.8% -$60.6K 0.07% 236
2025
Q3 		$7.46M Sell
11,679
-373
-3% -$226K 0.07% 258
2025
Q2 		$6.46M Sell
12,052
-156
-1% -$74.6K 0.06% 278
2025
Q1 		$5.13M Sell
12,208
-71
-0.6% -$30.8K 0.05% 313
2024
Q4 		$5.08M Buy
12,279
+77
+0.6% +$33.8K 0.05% 321
2024
Q3 		$6.16M Sell
12,202
-418
-3% -$203K 0.06% 291
2024
Q2 		$6.15M Buy
12,620
+60
+0.5% +$30.1K 0.06% 275
2024
Q1 		$6.78M Sell
12,560
-442
-3% -$242K 0.07% 255
2023
Q4 		$7.22M Buy
13,002
+89
+0.7% +$41.8K 0.07% 234
2023
Q3 		$5.65M Sell
12,913
-7
-0.1% -$3.49K 0.06% 285
2023
Q2 		$6.49M Sell
12,920
-38
-0.3% -$18.2K 0.07% 267
2023
Q1 		$6.48M Sell
12,958
-5,669
-30% -$2.71M 0.07% 280
2022
Q4 		$7.6M Sell
18,627
-204
-1% -$79.2K 0.09% 240
2022
Q3 		$6.13M Sell
18,831
-463
-2% -$170K 0.07% 261
2022
Q2 		$6.77M Buy
+19,294
New +$7.87M 0.08% 258

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York Life Investment Management's IDXX Position: Q2 2026 in Review

New York Life Investment Management reduced its Idexx Laboratories (IDXX) stake by 0.99% in Q2 2026, selling an estimated $66.2K and leaving 11,759 shares worth $6.19M. The position accounts for 0.04% of the portfolio, ranked #308.

New York Life Investment Management first reported a position in IDXX in Q2 2022 and has held it in 17 quarters since. The position peaked at $7.84M in Q4 2025. 997 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • New York Life Investment Management held 11,759 shares of Idexx Laboratories worth $6.19M as of Q2 2026.
  • New York Life Investment Management sold 118 Idexx Laboratories shares in Q2 2026, an estimated $66.2K.
  • Idexx Laboratories made up 0.04% of New York Life Investment Management's portfolio in Q2 2026, its #308 holding.
  • New York Life Investment Management first reported a position in Idexx Laboratories in Q2 2022 and has held it in 17 quarters since.
  • New York Life Investment Management's Idexx Laboratories position peaked at $7.84M in Q4 2025.
  • 997 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.